What is Chester Neurology?
Chester Neurology operates as a premier clinical provider specializing in the diagnosis and management of intricate neurological disorders, including Alzheimer's disease, epilepsy, and multiple sclerosis. Under the clinical leadership of Dr. Roshni Karnani, the practice has established a strong footprint in Westchester, Yonkers, and Manhattan. Beyond traditional neurology, the clinic distinguishes itself through the integration of advanced therapeutic modalities, such as Transcranial Magnetic Stimulation (TMS) and Spravato, specifically targeting treatment-resistant depression. This multidisciplinary approach positions the company as a critical node in the regional healthcare ecosystem, bridging the gap between high-acuity diagnostic services and patient-centric therapeutic support.
The firm's operational model emphasizes evidence-based care, ensuring that patients receive tailored interventions that prioritize long-term neurological health and overall well-being. By maintaining a focus on both chronic disease management and innovative mental health treatments, Chester Neurology effectively captures a diverse patient demographic, driving consistent demand for its specialized medical services.
How much funding has Chester Neurology raised?
Chester Neurology has raised a total of $44K across 1 funding round:
Debt
$44K
Debt (2021): $44K with participation from PPP
Key Investors in Chester Neurology
PPP
Public-Private Partnership
What's next for Chester Neurology?
With the recent infusion of capital, Chester Neurology is strategically positioned to accelerate its growth trajectory. The firm is expected to prioritize the expansion of its clinical facilities and the procurement of cutting-edge diagnostic technology to enhance patient throughput and diagnostic precision. Furthermore, the investment will likely support the scaling of its therapeutic programs, allowing for broader access to specialized treatments like TMS. As the company matures through its current lifecycle stage, the focus will shift toward optimizing operational efficiencies and potentially exploring new regional markets to solidify its competitive advantage in the neurology space. This strategic deployment of resources is designed to sustain long-term value creation while maintaining the high standard of clinical excellence that defines the practice.
See full Chester Neurology company page
